MELBOURNE, Australia, Aug. 31, 2011 /PRNewswire-Asia/ — Pharmaceutical company Hatchtech Pty Ltd has completed treatment of subjects for its Phase 2b clinical study to confirm the efficacy of its novel head lice treatment DeOvo™.
This Phase 2b trial is evaluating the efficacy,…
Popularity: 2% [?]

